Literature DB >> 8217526

In vivo assessment of mitochondrial functionality in human gastrocnemius muscle by 31P MRS. The role of pH in the evaluation of phosphocreatine and inorganic phosphate recoveries from exercise.

S Iotti1, R Lodi, C Frassineti, P Zaniol, B Barbiroli.   

Abstract

In this study we compared the kinetics of phosphocreatine (PCr) and P(i) recovery, and their dependency on cytosolic pH in 38 normal individuals. Spectra were acquired during rest, work and recovery. A time resolution of 10 s was used to obtain detailed information. The kinetics of PCr and P(i) recovery almost overlapped when the lowest value of cytosolic pH reached during recovery (termed the minimum pH) was < 6.95, while they were completely dissociated when the minimum pH was > 6.95. This result is interpreted as indirect in vivo evidence of the kinetic control exerted by ADP on mitochondrial oxidation. Our results represent a rationale for new experimental conditions to be used in clinical routine studies of pathologies due to primary or secondary mitochondrial malfunction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8217526     DOI: 10.1002/nbm.1940060404

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  33 in total

1.  31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients.

Authors:  S F E Praet; H M M De Feyter; R A M Jonkers; K Nicolay; C van Pul; H Kuipers; L J C van Loon; J J Prompers
Journal:  MAGMA       Date:  2006-12-19       Impact factor: 2.310

2.  Mitochondrial coupling in humans: assessment of the P/O2 ratio at the onset of calf exercise.

Authors:  V Cettolo; M Cautero; E Tam; M P Francescato
Journal:  Eur J Appl Physiol       Date:  2007-01-06       Impact factor: 3.078

3.  Muscle metabolic responses during high-intensity intermittent exercise measured by (31)P-MRS: relationship to the critical power concept.

Authors:  Weerapong Chidnok; Fred J DiMenna; Jonathan Fulford; Stephen J Bailey; Philip F Skiba; Anni Vanhatalo; Andrew M Jones
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-25       Impact factor: 3.619

4.  Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle.

Authors:  Vidhya Kumar; Henry Chang; David A Reiter; David P Bradley; Martha Belury; Shana E McCormack; Subha V Raman
Journal:  J Vis Exp       Date:  2017-01-19       Impact factor: 1.355

Review 5.  Brain and skeletal muscle bioenergetic failure in familial hypobetalipoproteinaemia.

Authors:  R Lodi; R Rinaldi; A Gaddi; S Iotti; R D'Alessandro; N Scoz; M Battino; V Carelli; G Azzimondi; P Zaniol; B Barbiroli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

6.  Influence of cytosolic pH on in vivo assessment of human muscle mitochondrial respiration by phosphorus magnetic resonance spectroscopy.

Authors:  R Lodi; G J Kemp; S Iotti; G K Radda; B Barbiroli
Journal:  MAGMA       Date:  1997-06       Impact factor: 2.310

7.  In vivo assessment of human skeletal muscle mitochondria respiration in health and disease.

Authors:  B Barbiroli; S Iotti; R Lodi
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

8.  Delayed reoxygenation after maximal isometric handgrip exercise in high oxidative capacity muscle.

Authors:  Ryotaro Kime; Takafumi Hamaoka; Takayuki Sako; Motohide Murakami; Toshiyuki Homma; Toshihito Katsumura; Britton Chance
Journal:  Eur J Appl Physiol       Date:  2002-12-24       Impact factor: 3.078

9.  Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy.

Authors:  B Barbiroli; R Medori; H J Tritschler; T Klopstock; P Seibel; H Reichmann; S Iotti; R Lodi; P Zaniol
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

10.  Cellular bioenergetics after erythropoietin therapy in chronic renal failure.

Authors:  R M Marrades; J Alonso; J Roca; J M González de Suso; J M Campistol; J A Barberá; O Diaz; J V Torregrosa; J R Masclans; R Rodríguez-Roisin; P D Wagner
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.